Small non-coding RNAs could be warning signs of cancer

Small non-coding RNAs can be used to predict if individuals have breast cancer, conclude researchers who contribute to The Cancer Genome Atlas project. The results, which are published in EMBO Reports, indicate that differences in the levels of specific types of non-coding RNAs can be used to distinguish between cancerous and non-cancerous tissues. These RNAs can also be used to classify cancer patients into subgroups of individuals that have different survival outcomes.

Small non-coding RNAs are RNA molecules that do not give rise to proteins but which may have other important functions in the cell. "For many years, small non-coding RNAs near transcriptional start sites have been regarded as 'transcriptional noise' due to their apparent chaotic distribution and an inability to correlate these molecules with known functions or disease," explains Steven Jones, one of the lead authors of the study, a professor at Simon Fraser University and the University of British Columbia, and a distinguished scientist at the BC Cancer Agency. "By using a computational approach to analyze small RNA sequence information that we generated as part of The Cancer Genome Atlas project, we have been able to filter through this noise to find clinically useful information," adds Jones. "The data from our experiments show that genome-wide changes in the expression levels of small non-coding RNAs in the first exons of protein-coding genes are associated with ."

The scientists were able to distinguish between the many different small non-coding RNAs that are found near the transcriptional start sites of genes in healthy individuals and patients with breast cancer (in this case, breast invasive carcinoma). They mapped these RNA molecules to specific locations on the DNA sequence and looked for correlations between the non-coding RNAs that were strongly expressed and the disease status of the patients from whom the tissue samples were isolated. The researchers then tested if the expression of the small RNAs in genomic locations that they were able to identify could be used to predict the presence of disease in another group of tissue samples obtained from patients known to have breast cancer. The test efficiently predicted the correct disease status for the samples in the new study group. "The potential to predict cancer status is restricted to only a subset of the many small non-coding RNAs found near transcription start sites of the genes. What's more, these RNA locations are highly enriched with CpG islands," says Athanasios Zovoilis, the first author of the study. CpG islands are genomic regions that contain a high frequency of cytosine and guanine. The presence of these RNAs in these islands may implicate their involvement with DNA methylation processes and the onset of disease but additional experiments are needed to explore and prove this link.

"This is the first time that small non-coding RNAs near the transcription start site of genes have been associated with disease," says Jones. "Further work is required but based on our data we believe there is considerable diagnostic potential for these small non-coding RNAs as a predictive tool for cancer. In addition, they may help us understand better the mechanisms underlying oncogenesis at the epigenetic level and lead to potential new drugs employing small non-coding RNAs." The researchers also note that this class of small non-coding RNAs may be useful in predicting the existence of other types of or disease.

The generation of data by The Cancer Genome Atlas project, which now provides access to large amounts of sequencing information for diseased and normal tissues, made the work possible. The Cancer Genome Atlas is now one of the largest resources for small non-coding RNAs in existence.

More information: The expression level of small non-coding RNAs derived from the first exon of protein coding genes is predictive of cancer status, Athanasios Zovoilis, Andrew J Mungall, Richard Moore, Richard Varhol, Andy Chu, Tina Wong, Marco Marra, Steven JM Jones, DOI: 10.1002/embr.201337950

add to favorites email to friend print save as pdf

Related Stories

Preventing the spread of repression

Aug 08, 2013

Scientists at the Friedrich Miescher Institute for Biomedical Research have identified a novel and unexpected regulatory activity of RNA at the edge of inactive chromosomal regions. In their publication in Nature Structural an ...

Unravelling the function of small RNAs

Aug 16, 2012

Small non-coding RNAs (ncRNAs) play a hitherto unrecognised role in regulation of gene expression. To broaden knowledge on the function and evolution of these molecules, a EU project investigated various ...

Scientists shed some light on biological "dark matter"

Jan 20, 2014

Biologists have studied the functionality of a poorly understood category of genes, which produce long non-coding RNA molecules rather than proteins. Some of these genes have been conserved throughout evolution, ...

RNA promotes metastasis in lung cancer

Feb 05, 2013

The vast majority – approximately 80 percent – of our DNA does not code for proteins, yet it gets transcribed into RNA. These RNA molecules are called non-coding and fulfill multiple tasks in the cell. Alongside a well-studied ...

Exploring lincRNA's role in breast cancer

Apr 08, 2013

Once considered part of the "junk" of our genome, much of the DNA between protein-coding genes is now known to be transcribed. New findings by scientists at Fox Chase Cancer Center have identified several dozen transcripts ...

Recommended for you

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.